Clough Capital Partners LP

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Clough Capital Partners LP
CRD #131257
SEC #801-63142
CIK #0001276144, 0001299406
AUM 1,508.7 M (2026-03-31)
Employees 11 (36% Investors, 18% Brokers)
Phone617-204-3400
Address53 State Street
Boston, MA 02109
Source [IAPD] [EDGAR] [Website] [LinkedIn] [Facebook]
Total AUM ($B)
6.04.83.62.41.20.02002201020182027
Sector Form 13F Holdings Value ($B)
Alphabet Inc 0.1
Carnival Corp 0.0
Nvidia Corp 0.0
Amazon Com Inc 0.0
Apple Inc 0.0
Chesapeake Energy Corp 0.0
PulteGroup Inc/MI/ 0.0
Eaton Corp Ltd 0.0
Boeing Co 0.0
Horton D R Inc /DE/ 0.0
View All
Holdings by Sector ($B)
4.03.22.41.60.80.02011201620212027
Type Form D Funds Date Sold AUM
HF CCP SPV LP [2019-03-29] 4.9 M 0.1 M
Filed 2018-04-10 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose
HF Clough Healthcare Master Fund LP [2016-03-30] 49.9 M 26.1 M
Filed 2025-04-02 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $1,000,000 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose
HF Clough Global Long/Short Fund LP 2015-03-31 5.1 M
HF Clough Emeth Master Fund LP [2013-10-17] 38.7 M 182.5 M
Filed 2015-10-08 (D) · Exemption 506(b), 3(c)(7) · Minimum $2,000,000 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose
HF Clough Asia Master Fund LP [2012-03-30] 31.2 M
HF Clough Investment Partners II LP [2012-03-30] 32.5 M 20.0 M
Filed 2025-04-02 (D/A) · Exemption 506(b), 3(c), 3(c)(1) · Minimum $2,000,000 · Remaining Indefinite · Duration More than one year · Commission $182,848 · Finder's Fee $644,286 · Net Assets Decline to Disclose
HF Clough Investment Partners I LP [2012-03-30] 1,058.2 M 165.4 M
Filed 2025-04-02 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $2,000,000 · Remaining Indefinite · Duration More than one year · Commission $365,093 · Finder's Fee $1,214,404 · Net Assets Decline to Disclose
HF Clough Offshore Fund Ltd 2012-03-30 15.6 M
HF Clough Offshore Fund QP Ltd 2012-03-30 60.0 M
AUM Breakdown Accounts AUM ($B)
By Client Type
(a) Individuals (other than high net worth individuals) 0 0.0
(b) Individuals (high net worth individuals) 0 0.0
(c) Banking or thrift institutions 0 0.0
(d) Investment companies 5 0.9
(e) Business development companies 0 0.0
(f) Pooled investment vehicles 4 0.2
(g) Pension and profit sharing plans 0 0.0
(h) Charitable organizations 1 0.4
(i) State or municipal government entities 0 0.0
(j) Other investment advisers 0 0.0
(k) Insurance companies 0 0.0
(l) Sovereign wealth funds and foreign official institutions 0 0.0
(m) Corporations or other businesses not listed above 0 0.0
(n) Other 0 0.0
Total 10 1.5
By Discretionary
Discretionary 10 1.5
Non-Discretionary 0 0.0
Total 10 1.5
By Non-United States Persons
Non-United States Persons 0.0
United States Persons 1.5
Total 10 1.5
Form D Directors Role # Filings # Firms 2011 - 2026
Eric Brock Executive Officer 21 3
Daniel Gillis Executive Officer 11 3
Clough Capital Partners LP Promoter 9 3
Charles Clough Jr Executive Officer 8 3
James Canty Executive Officer 7 3
Stephen Shorey Executive Officer 5 2
Clough Associates LLC Promoter 2 1
Ccp Associates LLC Executive Officer 1 1
Clough Emeth Associates LP Executive Officer 1 1
Clough Healthcare Associates LLC Promoter 1 1
View All
EDGAR Form CIK 2011 - 2026
13F-HR [0001276144]
SC 13G [0001276144]
4 [0001299406]
Form 13D/13G Filer Form 13D/13G Subject Filed
Clough Capital Partners L P Checkmate Pharmaceuticals Inc [2020-11-10]
Clough Capital Partners L P Correvio Pharma Corp [2020-02-24]
Clough Capital Partners L P Correvio Pharma Corp [2019-02-14]
Clough Capital Partners L P Carvana Co [2018-02-13]
Clough Capital Partners L P KURA Oncology Inc [2016-01-12]
Clough Capital Partners L P Healthways Inc [2016-01-12]
Clough Capital Partners L P Cardiome Pharma Corp [2015-08-14]
Clough Capital Partners L P Veracyte Inc [2015-06-01]
Firm Profile (Form ADV)
Discretionary AUM$5.0B
ServesInstitutional
Fund TypesHedge Fund
LEI549300EN8MICV62FEJ05
Form 3/4/5 Subject 2011 - 2026
Clough Capital Partners LP
Clough Global Dividend & Income Fund
Clough Global Opportunities Fund
Clough Global Equity Fund
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Clough Global Dividend & Income Fund GLV
Common shares of beneficial interest
2023-02-08 Buy 5,224 $6.25 32,650
Clough Global Dividend & Income Fund GLV
Common shares of beneficial interest
2023-02-08 Buy 1,176 $6.24 7,338
Clough Global Equity Fund GLQ
Common shares of beneficial interest
2023-02-08 Buy 14,351 $6.25 89,694
Clough Global Equity Fund GLQ
Common shares of beneficial interest
2023-02-08 Buy 600 $6.25 3,750
Clough Global Opportunities Fund GLO
Common shares of beneficial interest
2023-02-08 Buy 38,200 $5.05 192,910
Clough Global Opportunities Fund GLO
Common shares of beneficial interest
2023-02-08 Buy 4,800 $5.04 24,192
Clough Global Dividend & Income Fund GLV
Subscription Rights (Right to Buy) · derivative
2021-06-30 Option exercise 5,234 $10.15 53,125
Clough Global Dividend & Income Fund GLV
Common shares of beneficial interest
2021-06-30 Option exercise 5,234 $10.15 53,125
Clough Global Opportunities Fund GLO
Subscription Rights (right to buy) · derivative
2021-06-30 Option exercise 36,834 $11.59 426,906
Clough Global Opportunities Fund GLO
Common shares of beneficial interest
2021-06-30 Option exercise 36,834 $11.59 426,906
Clough Global Equity Fund GLQ
Subscription Rights (right to buy) · derivative
2021-06-30 Option exercise 14,199 $13.56 192,538
Clough Global Equity Fund GLQ
Common shares of beneficial interest
2021-06-30 Option exercise 14,199 $13.56 192,538
Clough Global Dividend & Income Fund GLV
Common shares of beneficial interest
2021-05-20 Buy 9 $12.07 109
Clough Global Dividend & Income Fund GLV
Common shares of beneficial interest
2021-05-20 Buy 1,900 $12.08 22,952
Clough Global Dividend & Income Fund GLV
Common shares of beneficial interest
2021-05-20 Buy 786 $12.04 9,463
Clough Global Dividend & Income Fund GLV
Common shares of beneficial interest
2021-05-20 Buy 1,400 $12.09 16,926
Clough Global Dividend & Income Fund GLV
Common shares of beneficial interest
2021-05-20 Buy 905 $12.10 10,950
Clough Global Dividend & Income Fund GLV
Common shares of beneficial interest
2021-05-19 Buy 300 $11.88 3,564
Clough Global Dividend & Income Fund GLV
Common shares of beneficial interest
2021-05-19 Buy 4,700 $11.89 55,883
Clough Global Equity Fund GLQ
Common shares of beneficial interest
2020-08-27 Buy 1,516 $11.95 18,116
showing 20 of 31 most recent transactions
Comparable Firms State AUM
Graticule Asia Macro Advisors LLC
1,536.9 M
Meteora Capital LLC
FL 1,536.0 M
Infinity Capital Advisors LLC
GA 1,530.9 M
Northwest Investment Management Hong Kong Limited
1,528.6 M
Stony Point Capital LLC
NY 1,494.7 M
Linear B Partners LP
NY 1,494.0 M
CCS Partners LLC
NY 1,489.1 M
Iso-MTS Capital Management LP
CT 1,488.5 M
Gabelli & Company Investment Advisers Inc
CT 1,482.5 M
Acuitas Investments LLC
WA 1,481.1 M
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com